相关实验视频

Updated: Jan 14, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

打破障碍:创新的治疗方法来管理同卵性家族性高胆固醇血症

Shuai-Jie Huang¹, Ping Huang¹, Nan-Nan Song¹

¹School of Pharmaceutical Sciences & Institute of Materia Medica, National Key Laboratory of Advanced Drug Delivery System, Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China.

Experimental and molecular pathology

|October 17, 2025

概括

同胞性家族性高胆固醇血症 (HoFH) 是一种影响胆固醇代谢的罕见遗传疾病. 本综述涵盖了HoFH的当前和新型治疗方法,解决了管理这种疾病的挑战.

科学领域:

遗传学是一个遗传学.
代谢障碍代谢障碍代谢障碍
心血管医学心血管医学

背景情况:

同胞性家族性胆固醇高血症 (HoFH) 是一种罕见的自体逆变性疾病,影响低密度脂蛋白胆固醇 (LDL-C) 代谢.
遗传变异,特别是LDLR基因,是HoFH的主要原因.
早期诊断和有效的降脂疗法 (LLT) 对于预防早发性动脉样硬化心血管疾病 (ASCVD) 至关重要.

研究的目的:

提供对HoFH的既定和新兴治疗剂的全面概述.
突出管理HoFH的挑战,包括对传统LLT的抵抗.
讨论新的药理学药剂和降胆固醇策略,用于HoFH治疗.

主要方法:

对HoFH.H的既定治疗方式的审查.
对新兴治疗剂的分析,包括那些独立于LDL-R活性的治疗剂.
讨论治疗差异和管理挑战.

主要成果:

大多数HoFH患者由于LDL-R功能受损而表现出对传统LLT的抗性.
像evolocumab,alirocumab,inclisiran,bempedoic acid,lomitapide和evinacumab这样的新药提供了新的治疗途径.
对于使用这些先进疗法来管理HoFH存在重大前景.

结论:

有效的LDL-C降低对于HoFH管理至关重要.
新型疗法为那些抗常规治疗的患者提供了希望.
解决全球治疗差异对于公平的HOFH护理至关重要.

关键词:

同胞性家族性高胆固醇血清症降脂疗法是一种降脂疗法.脂质蛋白非热症是指脂质蛋白的非热症.肝脏移植肝脏移植低密度脂蛋白受体的受体是低密度脂蛋白受体.PCSK9 抑制剂的使用.

更多相关视频

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

相关概念视频

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Atherosclerosis IV: Nursing Management

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...